Adverse Reactions/Side Effects The following adverse reactions are also discussed elsewhere in the labeling: Pancreatitis [see Warnings and Precautions (5.1)] Heart Failure [see Warnings and Precautions (5.2)] Acute Renal Failure [see Warnings and Precautions (5.3)] Hypoglycemia with Concomitant Use with Insulin or Insulin Secretagogues [see Warnings and Precautions (5.4)] Hypersensitivity Reactions [see Warnings and Precautions (5.5)] Severe and Disabling Arthralgia [see Warnings and Precautions (5.6)] Bullous Pemphigoid [see Warnings and Precautions (5.7)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice

On the physiological level, these improvements come with lower fasting insulin, C-peptide, and HOMA2-IR, which are all indicators of enhanced insulin sensitivity
This feeling is different from the expected appetite reduction these medications should cause
Common side effects include nausea, vomiting, constipation and diarrhea
Some, like insulin and GLP-1 agonists such as semaglutide, are among the most transformative medicines of our era